329 studies found for:    Spasticity
Show Display Options
RSS Create an RSS feed from your search for:
Spasticity
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
2 Recruiting Reliability of an Algorithm to Diagnose Spasticity
Condition: Spasticity
Intervention:
3 Completed Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Conditions: Spasticity;   Cerebral Palsy
Intervention: Drug: baclofen
4 Not yet recruiting Developing and Testing a Comprehensive MS Spasticity Management Program
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Behavioral: Spasticity: Take Control
5 Completed Prevalence of Spasticity in Veterans Living in a Long-term Care Facility
Condition: Spasticity
Intervention:
6 Completed
Has Results
Retrospective Study of Patients With Spasticity in the Spanish Population
Condition: Muscle Spasticity
Intervention: Other: No treatment
7 Completed
Has Results
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
8 Completed
Has Results
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Other: Placebo
9 Completed
Has Results
Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Drug: Placebo
10 Completed Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity
Condition: Muscle Spasticity
Intervention: Drug: Tizanidine (sublingual or oral)
11 Unknown  Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis
Condition: Muscle Spasticity Due to Multiple Sclerosis
Interventions: Drug: BGG492;   Drug: Placebo
12 Recruiting Early Use of Botulinum Toxin in Spasticity Post Stroke.
Conditions: Stroke;   Muscle Spasticity;   Contracture
Interventions: Drug: onabotulinumtoxinA;   Drug: Placebo
13 Completed
Has Results
A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
14 Withdrawn Continuous Intrathecal Baclofen Infusion for Chronic Spasticity
Condition: Spasticity
Intervention: Device: Prometra Programmable Implantable Pump System
15 Completed Vanderbilt University Spasticity Management Program Evaluation Plan
Condition: Spasticity
Interventions: Drug: Botulinum Toxin Type A;   Drug: Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB)
16 Suspended Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs
Condition: Muscle Spasticity
Intervention: Other: No Intervention
17 Unknown  A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
Condition: Spasticity
Intervention:
18 Completed Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: arbaclofen;   Drug: baclofen;   Drug: Placebo
19 Recruiting Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
Conditions: Cerebral Palsy;   Spasticity
Interventions: Drug: IncobotulinumtoxinA (8 Units per kg body weight);   Drug: IncobotulinumtoxinA (6 Units per kg body weight);   Drug: IncobotulinumtoxinA (2 Units per kg body weight)
20 Completed MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A;   Drug: Botulinum Toxin type A

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years